Results 121 to 130 of about 62,041 (172)

National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing. [PDF]

J Antimicrob Chemother
Martínez-Buitrago E, Zapata-Marín AF, Rubiano LC, Sañudo LM, Oñate JM, Lenis W, García-Góez JF, Álvarez JE, García-Morales C, Matías-Florentino M, Ávila-Ríos S.   +10 more
europepmc   +1 more source

Structure-Guided Design of Novel Diarylpyrimidine-Based NNRTIs Through a Comprehensive In Silico Approach: 3D-QSAR, ADMET Evaluation, Molecular Docking, and Molecular Dynamics. [PDF]

Pharmaceuticals (Basel)
Baassi M, Moussaoui M, Rajkhowa S, Soufi H, Daoud R, Belaaouad S.   +5 more
europepmc   +1 more source

David Baltimore: Scientist, leader, and mentor. [PDF]

Proc Natl Acad Sci U S A
Andrews NC, Daley GQ.
europepmc   +1 more source

Enzyme Selectivity of HIV Reverse Transcriptase: Conformations, Ligands, and Free Energy Partition. [PDF]

J Phys Chem B, 2015
Kirmizialtin S, Johnson KA, Elber R.
europepmc   +1 more source

Impact of V179D/E mutations on antiretroviral therapy outcomes in people living with HIV-1: a 3-year retrospective study. [PDF]

Front Cell Infect Microbiol
Lv S, Lan Y, Li Q, Ling X, Li J, Wen C, Li Y, Chen J, Chen X, Cai W, Tang X, Li L.   +11 more
europepmc   +1 more source

Molecular Epidemiological Surveillance of HIV-1 Genotypes and Drug Resistance Profiles in Wuhan, Central China. [PDF]

Viruses
Zhang Q, Yan M, Huang J, Liu Y, Wang H, Feng S, Dong Z, Abulimiti D, Wang Y, Liang K, Feng Y.   +10 more
europepmc   +1 more source

Accessing HIV Care to Irregular Migrants in Israel, 2019-2024. [PDF]

Viruses
Wagner T, Mor Z, Dickstein Y, Turner D, Kedem E, Levy I, Wieder-Finesod A, Elinav H, Eddin IN, Olshtain-Pops K, Elbirt D, Smolyakov R, Istomin V, Wax M, Gozlan Y, Mor O.   +15 more
europepmc   +1 more source

In-silico identification of phytochemical compounds from various medicinal plants as potent HIV-1 non-nucleoside reverse transcriptase inhibitors utilizing molecular docking and molecular dynamics simulations. [PDF]

Biol Methods Protoc
Danladi S, Adeniyi AA, Sani ZI, Temitope A.   +3 more
europepmc   +1 more source

The impact of the recent HIV non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors-based regimens on metabolic health outcomes: A narrative review. [PDF]

Biochem Biophys Rep
Sedibe A, Sibiya N, Nyakudya T, Gamede M.   +3 more
europepmc   +1 more source

A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV. [PDF]

Lancet Reg Health Am
Caldeira DB, Constant Vergara TR, Schechter M, Bicudo EL, Freitas Lopes CA, Brites C, Sprinz E, Fernandes JC, Silveira OS, Durães-Carvalho R, Galinskas J, Treitsman MS, Gomes de Sousa MD, de Figueiredo Fernandes M, Helfer MS, Grilo NA, Caseiro MM, Sanz Duro RL, Bassini AS, Hunter JR, Janini LM, Diaz RS.   +21 more
europepmc   +1 more source